Myovant Sciences Ltd. (NYSE:MYOV)

Stock Price: $26.89

+0 (0%)

Updated Feb 2, 2023 09:00 PM GMT+0000

Featured app

Invest now

<p>79% of retail CFD accounts lose money</p>

Overview

Financials

Statistics

Profile

Chart

Market Cap	2.61B
Revenue	0
Gross Profit	0
Shares Out	97.24M
EPS (ttm)
PE Ratio	0.0000
Forward PE	0.0000
Dividend Rate (ttm)	0.0000
Dividend Yield	0.0000

Trading Day	Feb 2
Last Price	$26.89
Previous Close	$26.89
Change ($)	0
Change (%)	0%
Day's Open	26.89
Day's Range	26.845 - 26.9
Day's Volume	1.31M
52 Week Range	7.67 - 27.03

About Myovant Sciences Ltd.

Myovant Sciences aspires to redefine care for women and for men through purpose-driven science, empowering medicines, and transformative advocacy. Myovant Sciences has one FDA-approved medicine, ORGOVYX™ (relugolix), for adult patients with advanced prostate cancer.

Its lead product candidate, relugolix combination tablet (relugolix 40 mg, estradiol 1.0 mg, and norethindrone acetate 0.5 mg), is under regulatory review in Europe and the U.S. for women with uterine fibroids and is under development for women with endometriosis.

Myovant Sciences is also developing MVT-602, an oligopeptide kisspeptin-1 receptor agonist, which has completed a Phase 2a study for female infertility as part of assisted reproduction. Sumitovant Biopharma, Ltd., a wholly owned subsidiary of Sumitomo Dainippon Pharma Co., Ltd., is its majority shareholder.

News

Myovant stock opened 35% up on Monday: here’s the catalyst October 3, 2022

Myovant Sciences provides an update on a supplemental new drug April 16, 2022

Quick info

Industry

Pharmaceutical Preparation Manufacturing

Sector

Manufacturing

Website

myovant.com

Ticker Symbol

MYOV

Exchange

New York Stock Exchange

Reporting Currency

USD

Myovant Sciences Ltd. income statements (2020) (USD)

	June 2020	June 2020	March 2020	March 2020
Total Revenue	N.A	N.A	N.A	N.A
Cost of Revenue	N.A	N.A	529K	529K
Gross Profit	N.A	N.A	-529K	-529K
Research & Development	44.19M	44.19M	41.71M	41.71M
Selling General & Admin	22.28M	22.28M	21.90M	21.90M
Operating Expense	N.A	N.A	64.14M	64.14M
Operating Income	-33.68M	-33.68M	-64.14M	-64.14M
Other Income Expense Net	1.49M	1.49M	-708K	-708K
EBIT	-33.68M	-33.68M	-64.14M	-64.14M
Interest Income	2.18M	2.18M	1.43M	1.43M
Pretax Income	-32.19M	-32.19M	-64.85M	-64.85M
Income Tax	672K	672K	62K	62K
Minority Interest	0	0	0	0
Net Income	-32.86M	-32.86M	-64.91M	-64.91M
Net Income Basic	-32.86M	-32.86M	-64.91M	-64.91M

Myovant Sciences Ltd. income statements (2019) (USD)

	December 2019	September 2019	June 2019	March 2019
Total Revenue	N.A	N.A	N.A	N.A
Cost of Revenue	510K	370K	356K	140K
Gross Profit	-510K	-370K	-356K	-140K
Research & Development	48.93M	50.80M	51.12M	59.02M
Selling General & Admin	28.63M	16.23M	13.80M	12.34M
Operating Expense	78.07M	67.41M	65.27M	71.50M
Operating Income	-78.07M	-67.41M	-65.27M	-71.5M
Other Income Expense Net	-7.34M	-2.97M	-2.32M	-3.27M
EBIT	-78.07M	-67.41M	-65.27M	-71.5M
Interest Income	3.66M	3.79M	3.79M	3.91M
Pretax Income	-85.41M	-70.37M	-67.59M	-74.77M
Income Tax	191K	195K	313K	243K
Minority Interest	0	0	0	0
Net Income	-85.6M	-70.57M	-67.9M	-75.01M
Net Income Basic	-85.6M	-70.57M	-67.9M	-75.01M

Myovant Sciences Ltd. income statements (2018) (USD)

	December 2018	September 2018	June 2018	March 2018
Total Revenue	N.A	N.A	N.A	N.A
Cost of Revenue	107K	100K	91K	76K
Gross Profit	-107K	-100K	-91K	-76K
Research & Development	58.43M	53.81M	51.34M	40.08M
Selling General & Admin	10.58M	10.21M	8.65M	7.19M
Operating Expense	69.12M	64.12M	60.08M	47.35M
Operating Income	-69.12M	-64.12M	-60.08M	-47.35M
Other Income Expense Net	-1.51M	-1.56M	-1.91M	-1.3M
EBIT	-69.12M	-64.12M	-60.08M	-47.35M
Interest Income	1.63M	1.58M	1.62M	1.14M
Pretax Income	-70.63M	-65.68M	-61.99M	-48.65M
Income Tax	N.A	88K	145K	-394K
Minority Interest	0	0	0	0
Net Income	-70.63M	-65.77M	-62.13M	-48.25M
Net Income Basic	-70.63M	-65.77M	-62.13M	-48.25M

Myovant Sciences Ltd. income statements (2017) (USD)

	December 2017	September 2017	June 2017
Total Revenue	N.A	N.A	N.A
Cost of Revenue	63K	54K	50K
Gross Profit	-63K	-54K	-50K
Research & Development	34.88M	24.17M	17.71M
Selling General & Admin	6.58M	6.09M	4.13M
Operating Expense	41.52M	30.31M	21.89M
Operating Income	-41.52M	-30.31M	-21.89M
Other Income Expense Net	-475K	138K	-342K
EBIT	-41.52M	-30.31M	-21.89M
Interest Income	0.90M	N.A	N.A
Pretax Income	-41.99M	-30.17M	-22.23M
Income Tax	-213K	-265K	1.09M
Minority Interest	0	0	0
Net Income	-41.78M	-29.91M	-23.32M
Net Income Basic	-41.78M	-29.91M	-23.32M

Myovant Sciences Ltd. balance sheet (2020) (USD)

	June 2020	March 2020
Current Cash	84.73M	76.64M
Receivables	N.A	N.A
Inventory	N.A	N.A
Current Assets	109.07M	87.91M
Other Current Assets	9.37M	8.27M
Short Term Investments	14.97M	3M
Long Term Investments	1.37M	1.37M
Property/Plant Equipment	13.24M	13.64M
Good Will	N.A	N.A
Intangible Assets	N.A	N.A
Tangible Assets (Net)	-134.61M	-108.28M
Other Assets	3M	3M
Total Assets	126.68M	105.93M
Accounts Payable	5.39M	15.33M
Other Current Liabilities	45.61M	69.08M
Total Current Liabilities	52.58M	85.93M
Total Liabilities	261.29M	214.20M
Long Term Debt	204.27M	124.70M
Current Long Term Debt	N.A	N.A
Minority Interest	0	0
Common Stock	90.14M	89.83M
Treasury Stock	N.A	N.A
Retained Earnings	-823.87M	-791.01M
Capital Surplus	694.38M	684.38M
Shareholder Equity	-134.61M	-108.28M
Other Liabilities	N.A	N.A

Myovant Sciences Ltd. balance sheet (2019) (USD)

	December 2019	September 2019	June 2019	March 2019
Current Cash	83.07M	130.37M	226.73M	156.07M
Receivables	N.A	N.A	N.A	N.A
Inventory	N.A	N.A	N.A	N.A
Current Assets	110.97M	167.58M	235.76M	166.79M
Other Current Assets	12.09M	9.97M	8.69M	10.19M
Short Term Investments	15.82M	27.22M	N.A	N.A
Long Term Investments	1.37M	1.37M	1.13M	N.A
Property/Plant Equipment	13.90M	11.26M	11.24M	2.07M
Good Will	N.A	N.A	N.A	N.A
Intangible Assets	N.A	N.A	N.A	N.A
Tangible Assets (Net)	-48.89M	17.25M	79.57M	4.33M
Other Assets	3.26M	3.79M	2.75M	4.11M
Total Assets	129.51M	184M	250.87M	172.98M
Accounts Payable	6.62M	5.82M	10M	11.02M
Other Current Liabilities	45.23M	44.96M	47.21M	54.81M
Total Current Liabilities	53.30M	60.03M	68.90M	71.97M
Total Liabilities	178.40M	166.75M	171.31M	168.64M
Long Term Debt	125.10M	101.40M	98.62M	93.24M
Current Long Term Debt	N.A	8.40M	10.87M	6.14M
Minority Interest	0	0	0	0
Common Stock	89.79M	89.62M	89.62M	72.06M
Treasury Stock	N.A	N.A	N.A	N.A
Retained Earnings	-726.1M	-640.5M	-569.93M	-502.03M
Capital Surplus	678.03M	657.78M	649.81M	505.85M
Shareholder Equity	-48.89M	17.25M	79.57M	4.33M
Other Liabilities	N.A	N.A	N.A	N.A

Myovant Sciences Ltd. balance sheet (2018) (USD)

	December 2018	September 2018	June 2018	March 2018
Current Cash	183M	154.32M	N.A	108.62M
Receivables	N.A	N.A	N.A	N.A
Inventory	N.A	N.A	N.A	N.A
Current Assets	196.17M	163.53M	150.19M	114.76M
Other Current Assets	12.40M	8.45M	5.70M	5.14M
Short Term Investments	N.A	N.A	N.A	N.A
Long Term Investments	600K	N.A	N.A	N.A
Property/Plant Equipment	1.69M	1.47M	1.38M	1.27M
Good Will	N.A	N.A	N.A	N.A
Intangible Assets	N.A	N.A	N.A	N.A
Tangible Assets (Net)	46.74M	74.10M	60.16M	37.73M
Other Assets	3.21M	3.16M	2.78M	3.07M
Total Assets	201.67M	168.17M	154.35M	119.10M
Accounts Payable	5.47M	8.36M	5.04M	4.58M
Other Current Liabilities	48.88M	39.61M	43.88M	32.51M
Total Current Liabilities	55.87M	47.97M	48.92M	37.09M
Total Liabilities	154.94M	94.07M	94.19M	81.37M
Long Term Debt	97.16M	44.56M	44.13M	43.62M
Current Long Term Debt	1.52M	N.A	N.A	N.A
Minority Interest	0	0	0	0
Common Stock	70.80M	68.48M	64.89M	61M
Treasury Stock	N.A	N.A	N.A	N.A
Retained Earnings	-427.01M	-356.38M	-290.61M	-228.47M
Capital Surplus	473.52M	430.10M	350.31M	266.18M
Shareholder Equity	46.74M	74.10M	60.16M	37.73M
Other Liabilities	N.A	N.A	N.A	N.A

Myovant Sciences Ltd. balance sheet (2017) (USD)

	December 2017	September 2017	June 2017
Current Cash	128.87M	129.33M	154.19M
Receivables	N.A	N.A	N.A
Inventory	N.A	N.A	N.A
Current Assets	134.76M	133.07M	159.37M
Other Current Assets	5.28M	3.74M	5.18M
Short Term Investments	N.A	N.A	N.A
Long Term Investments	N.A	N.A	N.A
Property/Plant Equipment	1.12M	0.97M	0.95M
Good Will	N.A	N.A	N.A
Intangible Assets	N.A	N.A	N.A
Tangible Assets (Net)	82.20M	118.72M	145.98M
Other Assets	2.10M	2.10M	3.07M
Total Assets	137.98M	136.13M	163.40M
Accounts Payable	2.09M	N.A	N.A
Other Current Liabilities	24.64M	16.63M	16.48M
Total Current Liabilities	26.73M	17.09M	17.20M
Total Liabilities	55.78M	17.41M	17.42M
Long Term Debt	28.58M	N.A	N.A
Current Long Term Debt	N.A	N.A	N.A
Minority Interest	0	0	0
Common Stock	60.99M	60.85M	60.84M
Treasury Stock	N.A	N.A	N.A
Retained Earnings	-180.22M	-138.44M	-108.54M
Capital Surplus	262.51M	256.88M	254.11M
Shareholder Equity	82.20M	118.72M	145.98M
Other Liabilities	N.A	N.A	N.A

Myovant Sciences Ltd. cash flow (2020) (USD)

	June 2020	March 2020
Net Income	-32.86M	-64.91M
Depreciation	551K	529K
Changes in Receivables	N.A	N.A
Changes in Inventories	N.A	N.A
Cash Change	8.08M	-6.43M
Cash Flow	-61.63M	-18.89M
Capital Expenditures	-151K	-275K
Investments	-11.97M	12.80M
Investing Activity (other)	N.A	N.A
Total Investing Cash Flows	-12.12M	12.53M
Dividends Paid	N.A	N.A
Net Borrowings	79.64M	-335K
Other Financing Cash Flows	N.A	N.A
Cash Flow Financing	81.83M	-60K
Exchange Rate Effect	N.A	N.A

Myovant Sciences Ltd. cash flow (2019) (USD)

	December 2019	September 2019	June 2019	March 2019
Net Income	-85.6M	-70.57M	-67.9M	-75.01M
Depreciation	510K	370K	356K	140K
Changes in Receivables	N.A	N.A	N.A	N.A
Changes in Inventories	N.A	N.A	N.A	N.A
Cash Change	-47.3M	-96.11M	70.66M	-26.4M
Cash Flow	-66.62M	-67.97M	-66.81M	-53.11M
Capital Expenditures	-292K	-393K	-139K	-518K
Investments	11.52M	-27.16M	N.A	N.A
Investing Activity (other)	N.A	N.A	N.A	N.A
Total Investing Cash Flows	11.23M	-27.55M	-139K	-518K
Dividends Paid	N.A	N.A	N.A	N.A
Net Borrowings	7.80M	-368K	N.A	-26K
Other Financing Cash Flows	N.A	N.A	N.A	N.A
Cash Flow Financing	8.08M	-590K	137.61M	27.22M
Exchange Rate Effect	N.A	N.A	N.A	N.A

Myovant Sciences Ltd. cash flow (2018) (USD)

	December 2018	September 2018	June 2018	March 2018
Net Income	-70.63M	-65.77M	-62.13M	-48.25M
Depreciation	107K	100K	91K	76K
Changes in Receivables	N.A	N.A	N.A	N.A
Changes in Inventories	N.A	N.A	N.A	N.A
Cash Change	29.29M	10.68M	35.01M	-20.25M
Cash Flow	-62.1M	-64.13M	-44.76M	-34.99M
Capital Expenditures	-328K	-193K	-197K	-229K
Investments	N.A	N.A	N.A	N.A
Investing Activity (other)	N.A	N.A	N.A	N.A
Total Investing Cash Flows	-328K	-193K	-197K	-229K
Dividends Paid	N.A	N.A	N.A	N.A
Net Borrowings	54M	N.A	N.A	14.95M
Other Financing Cash Flows	-300K	N.A	N.A	N.A
Cash Flow Financing	91.71M	75M	79.96M	14.97M
Exchange Rate Effect	N.A	N.A	N.A	N.A

Myovant Sciences Ltd. cash flow (2017) (USD)

	December 2017	September 2017	June 2017
Net Income	-41.78M	-29.91M	-23.32M
Depreciation	63K	54K	50K
Changes in Receivables	N.A	N.A	N.A
Changes in Inventories	N.A	N.A	N.A
Cash Change	-459K	-24.86M	-26.65M
Cash Flow	-30.91M	-24.8M	-26.56M
Capital Expenditures	-218K	-67K	-90K
Investments	N.A	N.A	N.A
Investing Activity (other)	N.A	N.A	N.A
Total Investing Cash Flows	-218K	-67K	-90K
Dividends Paid	N.A	N.A	N.A
Net Borrowings	28.80M	N.A	N.A
Other Financing Cash Flows	N.A	N.A	N.A
Cash Flow Financing	30.66M	12K	N.A
Exchange Rate Effect	N.A	N.A	N.A

Myovant Sciences Ltd. (NYSE:MYOV)

About Myovant Sciences Ltd.

News

Quick info

Myovant Sciences Ltd. income statements (2020) (USD)

Myovant Sciences Ltd. income statements (2019) (USD)

Myovant Sciences Ltd. income statements (2018) (USD)

Myovant Sciences Ltd. income statements (2017) (USD)

Myovant Sciences Ltd. balance sheet (2020) (USD)

Myovant Sciences Ltd. balance sheet (2019) (USD)

Myovant Sciences Ltd. balance sheet (2018) (USD)

Myovant Sciences Ltd. balance sheet (2017) (USD)

Myovant Sciences Ltd. cash flow (2020) (USD)

Myovant Sciences Ltd. cash flow (2019) (USD)

Myovant Sciences Ltd. cash flow (2018) (USD)

Myovant Sciences Ltd. cash flow (2017) (USD)

Myovant Sciences Ltd. dividends (USD)

Total Valuation

Important Dates

Share Statistics

Valuation Ratios

Stock Price Statistics

Income Statement

About

Key Executives